Malakoff Humanis
Also known as Groupe Malakoff Humanis, MH Innov’
French joint-managed social-protection group (health, provident, savings, Agirc-Arrco pensions) with €41.5B of investments (2025); LP in about 154 unlisted funds; runs the €250M MH Innov’ CVC.
- HEADQUARTERS
- Paris, France
- FOUNDED
- 2019
- OUTSIDE CAPITAL
- No — own capital only
- TEAM LISTED
- 6 people
FOCUS
- STAGES
- Pre-SeedSeed
- SECTORS
- HealthTechFintech
- ASSET MIX
- Private equityPrivate creditVenture capitalImpactReal estate
- GEOGRAPHY
- EuropeFrance
WHAT IT IS
Institutional LP. Pension funds, endowments, foundations and sovereign funds that commit capital to funds and, sometimes, directly.
- Corporate investment fund of the group, launched in 2018 with €250M; invests directly or via VC partners (Eurazeo and Elaia Partners) in health, insurance, HR and savings startups
ABOUT
Malakoff Humanis was formed in January 2019 from the combination of the Malakoff Médéric and Humanis groups; it is a non-profit social-protection group with joint (paritaire) and mutual governance covering health, provident, savings and Agirc-Arrco supplementary pensions. Its investments excluding savings were about €41.5B at 31 December 2025, of which €2.3B unlisted (private debt, private equity, infrastructure equity and acquisition debt across about 154 funds) and €2.6B real estate, with management delegated mainly to Sienna, Ostrum, Amundi and La Banque Postale AM. Named commitments include €80M to Sienna Biodiversity Private Credit (2024), Eiffel Energy Transition III and Impact Partners’ Impact Growth V. Its corporate fund MH Innov’ (2018, €250M) backs health, insurtech, HR, impact and savings startups directly and through funds run with Eurazeo and Elaia.
PORTFOLIO (9)
- Sienna Biodiversity Private Credit (Sienna IM) — €80M subscribedNOTABLEClimate & Energy · since 2024
- Eiffel Energy Transition III (Eiffel Investment Group)Climate & Energy
- Impact Growth V (Impact Partners)
- MH Innov’ fund managed by Eurazeo (formerly Idinvest), Malakoff Humanis sole LP
- MH Innov’ deeptech seed fund with ElaiaDeep Tech
- Health For People (H4P)HealthTech
- SêmeiaHealthTech
- i-VirtualHealthTech · since 2023
- FasstFintech
TEAM
- Thomas SaunierChief Executive Officer (Directeur général) · source
- Gauthier LalandeExecutive Director, MH Innov’ · source
- Anne Laure Del DucaBusiness Partner HR Services, MH Innov’ · source
- Pierre Amaury Roux de LusignanBusiness Partner Digital Health, MH Innov’ · source
- Franck MenutBusiness Partner Insurtech, MH Innov’ · source
- Laurent LitolffBusiness Partner Impact and Savings, MH Innov’ · source
LINKS
FAQ
Malakoff Humanis is a institutional investor based in Paris, France, founded in 2019.
Yes. Malakoff Humanis invests directly in private companies. It also commits capital to third-party funds as an LP.
Malakoff Humanis invests at Pre-Seed and Seed stages in HealthTech and Fintech.
Malakoff Humanis's stated ticket size is €300K–€3M.
Key people at Malakoff Humanis include Thomas Saunier (Chief Executive Officer (Directeur général)), Gauthier Lalande (Executive Director, MH Innov’), Anne Laure Del Duca (Business Partner HR Services, MH Innov’) and Pierre Amaury Roux de Lusignan (Business Partner Digital Health, MH Innov’).
Malakoff Humanis's investments include Sienna Biodiversity Private Credit (Sienna IM) — €80M subscribed, Eiffel Energy Transition III (Eiffel Investment Group), Impact Growth V (Impact Partners), MH Innov’ fund managed by Eurazeo (formerly Idinvest), Malakoff Humanis sole LP, MH Innov’ deeptech seed fund with Elaia, Health For People (H4P), Sêmeia and i-Virtual, among others.
Malakoff Humanis states that it accepts submissions through its official contact page.
No. Malakoff Humanis invests its own capital and does not raise money from outside investors.